Smallcapvoice.com, Inc.

On this call Medical Marijuana, Inc. (Pink Sheets: MJNA) CEO Dr. Stuart Titus and COO Blake Schroeder provide updates on the financial and operational performance of the Company in the second quarter of 2019, share recent research and development progress, and discuss where the company is headed for the remainder of the year and in the future. Second Quarter 2019 Financial and Operating Highlights Record revenue of $20.7 million in the second quarter of 2019, a 30.8% increase over the same quarter in 2018; 13 of 14 quarters of sequential revenue growth; Generated $1.4 million of cash from operations, with total cash balance increasing to $5.4 million at quarter end; Gross Profit of $15.4 million in the second quarter of 2019, a 61% increase over the same quarter in 2018; Adjusted EBITDA of $1.5 million in the second quarter of 2019, an increase of 129% over the same quarter in 2018; Cost of Goods Sold decreased as a percentage of sales from 39% in Q2 of 2018 to 26% in Q2 of 2019, resulting in gross pro